Profil

Jennotte Olivier

Département de pharmacie > Pharmacie galénique

CIRM

See author's contact details
Main Referenced Co-authors
Evrard, Brigitte  (39)
Lechanteur, Anna  (39)
Koch, Nathan  (28)
Parulski, Chloé  (8)
Gresse, Eva  (7)
Main Referenced Keywords
Itraconazole (5); Solubility enhancement (5); 3D Printing (4); atorvastatin (4); Fused Deposition Modeling (4);
Main Referenced Unit & Research Centers
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] (10)
Center for Interdisciplinary Research on Medicines (CIRM) (3)
Center for Education and Research on Macromolecules (CERM) (1)
Centre Interfacultaire de Recherche du Médicament - CIRM (1)
Complex and Entangled Systems from Atoms to Materials (CESAM) Research Unit (1)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (40)
Materials science & engineering (1)
Chemistry (1)

Publications (total 40)

The most downloaded
280 downloads
Jennotte, O. (2023). Comparison of different methods for shaping amorphous solid dispersions [Doctoral thesis, ULiège - University of Liège [BE]]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/305042 https://hdl.handle.net/2268/305042

The most cited

81 citations (Scopus®)

Parulski, C., Jennotte, O., Lechanteur, A., & Evrard, B. (August 2021). Challenges of fused deposition modeling 3D printing in pharmaceutical applications: Where are we now? Advanced Drug Delivery Reviews, 175. doi:10.1016/j.addr.2021.05.020 https://hdl.handle.net/2268/261087

Koch, N., Jennotte, O., Bourcy, Q., Lechanteur, A., DEVILLE, M., Charlier, C., CHIAP, P., Cardot, J. M., & Evrard, B. (27 April 2024). Evaluation of amorphous and lipid-based formulation strategies to increase the in vivo cannabidiol bioavailability in piglets. International Journal of Pharmaceutics, 657, 124173. doi:10.1016/j.ijpharm.2024.124173
Peer Reviewed verified by ORBi

Ayyoubi, S., Jennotte, O., Lechanteur, A., Evrard, B., & Ruigjrok, L. (21 April 2024). Will 3D printing replace manual compounding? [Poster presentation]. PBP World meeting, Vienne, Austria.

Koch, N., Jennotte, O., Lechanteur, A., Grignard, B., & Evrard, B. (17 January 2024). Improvement of aqueous solubility of active pharmaceutical ingredients by using mesoporous silica impregnation under pressurized carbon dioxide [Paper presentation]. 1st FRITCO2T Day.
Peer reviewed

Koch, N., Jennotte, O., Lechanteur, A., DEVILLE, M., Charlier, C., Cardot Jean-Michel, CHIAP, P., & Evrard, B. (2024). An Intravenous Pharmacokinetic Study of Cannabidiol Solutions in Piglets through the Application of a Validated Ultra-High-Pressure Liquid Chromatography Coupled to Tandem Mass Spectrometry Method for the Simultaneous Quantification of CBD and Its Carboxylated Metabolite in Plasma. Pharmaceutics. doi:10.3390/pharmaceutics16010140
Peer Reviewed verified by ORBi

Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (September 2023). Formulation and quality consideration of cannabidiol printed forms produced by fused-deposition modeling. Journal of Drug Delivery Science and Technology, 87, 104837. doi:10.1016/j.jddst.2023.104837
Peer reviewed

Jennotte, O. (2023). Comparison of different methods for shaping amorphous solid dispersions [Doctoral thesis, ULiège - University of Liège [BE]]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/305042

Jennotte, O., Lechanteur, A., Koch, N., Evrard, B., Rosoux François, Emmerechts Carl, & Beeckman Eric. (20 March 2023). Formulation and Quality Consideration of Printed Tablets of Cannabidiol Produced by Direct Powder Extrusion [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France.

Koch, N., Jennotte, O., Bourcy, Q., Lechanteur, A., & Evrard, B. (2023). How the choice of dissolution parameters influences the interpretation of dissolution efficiency from two different cannabidiol formulations? [Paper presentation]. CIRM day 2023.

Koch, N., Jennotte, O., Toussaint, C., Lechanteur, A., & Evrard, B. (2023). Production challenges of tablets containing lipid excipients: case study using cannabidiol as drug model. International Journal of Pharmaceutics, 122639. doi:10.1016/j.ijpharm.2023.122639
Peer Reviewed verified by ORBi

Koch, N., Jennotte, O., Bourcy, Q., Lechanteur, A., Chiap, P., & Evrard, B. (2023). How the choice of dissolution parameters influences the interpretation of dissolution efficiency from two different cannabidiol formulations? [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France.

Nyamba, I., Jennotte, O., Charles B Sombié, Lechanteur, A., Sacre, P.-Y., Abdoulaye Djandé, Rasmane Semde, & Evrard, B. (2023). Preformulation study for the selection of a suitable polymer for the development of ellagic acid-based solid dispersion using hot-melt extrusion. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2023.123088
Peer Reviewed verified by ORBi

Parulski, C., Gresse, E., Jennotte, O., Felten, A., Ziemons, E., Lechanteur, A., & Evrard, B. (31 August 2022). Fused deposition modeling 3D printing of solid oral dosage forms containing amorphous solid dispersions: How to elucidate drug dissolution mechanisms through surface spectral analysis techniques? International Journal of Pharmaceutics, 626, 122157. doi:10.1016/j.ijpharm.2022.122157
Peer Reviewed verified by ORBi

Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (2022). Development of amorphous solid dispersions of cannabidiol: Influence of the carrier, the hot-melt extrusion parameters and the use of a crystallization inhibitor. Journal of Drug Delivery Science and Technology, 103372. doi:10.1016/j.jddst.2022.103372
Peer reviewed

Jennotte, O., Koch, N., Rosoux, F., Emmerechts Carl, Beeckman Eric, Lechanteur, A., & Evrard, B. (30 March 2022). Formulation and Quality Consideration of Cannabidiol Printlets Produced by Fused-Deposition Modeling [Poster presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (30 March 2022). How do polymer composition and infill density of 3D printed oral forms influence the dissolution rate of a BCSII molecule ? [Poster presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP), Rotterdam, Netherlands.

Nyamba, I., Jennotte, O., Charles B Sombié, Lechanteur, A., Rasmané Semdé, & Evrard, B. (27 March 2022). Polymer screening for the development of solid dispersion formulations based on ellagic acid by Hot melt extrusion [Poster presentation]. world meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology, Rotterdam, Netherlands.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (10 March 2022). How do infill density and polymer composition of 3D printed solid oral forms impact the dissolution profile of a BSCII drug ? [Paper presentation]. CRS Local Chapters meeting Aachen, Aachen, Germany.

Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (March 2022). Cannabidiol tablets with an enhanced bioavailability: Optimal selection of excipients and tableting through Design of Experiments [Poster presentation]. PBP 13th World Meeting, Rotterdam, Netherlands.

Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (02 February 2022). Development of cannabidiol lipid-dispersion tablets: excipients selection and tabletability [Paper presentation]. CIRM Day 2022.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (02 February 2022). Developement of stable amorphous solid dispersions by hot-melt extrusion coupled with 3D printing to enhance the dissolution rate of a BCSII active molecule: Impact of infill density and polymer composition [Paper presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium.

Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (02 February 2022). Formulation and Quality Consideration of Cannabidiol Printlets Produced by Fused-Deposition Modeling [Paper presentation]. CIRM DAY 2022.

Koch, N., Jennotte, O., Ziemons, E., Boussard, G., Lechanteur, A., & Evrard, B. (2022). Influence of API physico-chemical properties on amorphization capacity of several mesoporous silica loading methods. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2021.121372
Peer Reviewed verified by ORBi

Parulski, C., Jennotte, O., Lechanteur, A., & Evrard, B. (August 2021). Challenges of fused deposition modeling 3D printing in pharmaceutical applications: Where are we now? Advanced Drug Delivery Reviews, 175. doi:10.1016/j.addr.2021.05.020
Peer Reviewed verified by ORBi

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (26 May 2021). How do polymer composition and infill density of 3D printed tablets influence the dissolution rate of itraconazole ? [Paper presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium.

Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (14 May 2021). Improvement of fenofibrate aqueous solubility by using mesoporous silica impregnation under pressurized carbon dioxide [Poster presentation]. PBP 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (06 April 2021). Amorphous solid dispersions of cannabidiol with an increase of the aqueous solubility: influence of the carrier, the hot melt extrusion parameters and the use of a crystallization inhibitor [Paper presentation]. The Controlled Release Society BeNeLux&France Early Career Scientists Meeting 2021.

Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (06 April 2021). Influence of API physico-chemical properties on amorphization capacity of several mesoporous silica loading methods [Paper presentation]. CRS BNFL ECS Meeting 2021.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (06 April 2021). How do infill density and polymer composition of tablets produced by hotmelt extrusion coupled with Fused Deposition Modeling 3D printing influence the dissolution profile of a BCS II molecule ? [Paper presentation]. CRS Local Chapter Meeting.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (04 March 2021). Investigation of the impact of polymer composition and infill density of solid oral forms produced by hot-melt extrusion coupled with 3D printing on the dissolution rate of itraconazole [Paper presentation]. CRS Local Chapter Meeting, Aachen, Germany.

Koch, N., Jennotte, O., Grignard, B., Lechanteur, A., & Evrard, B. (01 July 2020). Impregnation of mesoporous silica with poor aqueous soluble molecule using pressurized carbon dioxide: is the solubility in the supercritical and subcritical phase a critical parameter? European Journal of Pharmaceutical Sciences, 150, 105332. doi:10.1016/j.ejps.2020.105332
Peer Reviewed verified by ORBi

Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (2020). Three-dimensional printing technology as a promising tool in bioavailability enhancement of poorly water-soluble molecules: a review. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2020.119200
Peer Reviewed verified by ORBi

Koch, N., Jennotte, O., Gasparrini, Y., Vandenbroucke, F., Lechanteur, A., & Evrard, B. (2020). Cannabidiol aqueous solubility enhancement: comparison of three amorphous formulations strategies using different type of polymers. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2020.119812
Peer Reviewed verified by ORBi

Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (11 December 2019). Improvement of fenofibrate aqueous solubility by using mesoporous silica impregnation under pressurized carbon dioxide [Paper presentation]. 2nd CIRM Day.

Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (11 December 2019). Hot-melt extrusion as a solvent-free technique for the formation of a polymeric amorphous solid dispersion of atorvastatin [Paper presentation]. Second scientific CIRM day, Liège, Belgium.

Jennotte, O., Koch, N., Rocks, N., Lechanteur, A., & Evrard, B. (20 May 2019). Development of new manufacturing processes for amorphous solid dispersions [Paper presentation]. 20th forum of pharmaceutical sciences, Bruxelles, Belgium.

Koch, N., Jennotte, O., Rocks, N., Lechanteur, A., & Evrard, B. (20 May 2019). Mesoporous silica impregnation using supercritical carbon dioxide: is the solubility in the supercritical fluid a critical parameter? [Paper presentation]. 20th Forum of Pharmaceutical Sciences, Bruxelles, Belgium.

Jennotte, O., Koch, N. (Other coll.), Collard, L. (Other coll.), Lechanteur, A. (Other coll.), & Evrard, B. (Other coll.). (26 March 2019). Hot melt extrusion as a solvent-free technique for the formation of a polymeric amorphous solid dispersion of atorvastatin [Poster presentation]. 3rd European Conference on Pharmaceutics, Bologne, Italy.

Koch, N., Jennotte, O., Rocks, N., Lechanteur, A., & Evrard, B. (26 March 2019). Impregnation of mesoporous silica using supercritical-CO2: is the solubility in the supercritical fluid a critical paramter? [Poster presentation]. 3rd European Conference on Pharmaceutics, Bologne, Italy.

Jennotte, O., Koch, N., Collard, L., Lechanteur, A., & Evrard, B. (19 December 2018). Hot melt extrusion as a solvent-free technique for the formation of a polymeric amorphous solid dispersion of atorvastatin [Paper presentation]. CIRM Day, Liège, Belgium.

Koch, N., Jennotte, O., Rocks, N., Lechanteur, A., & Evrard, B. (December 2018). Impregnation of mesoporous silica with fenofibrate using supercritical-CO2: is the solubility a critical parameter? [Paper presentation]. 1st CIRM scientific Day, Liège, Belgium.

Contact ORBi